Dr. Reddy's tocilizumab biosimilar candidate 'DRL_TC' meets primary and secondary endpoints in Phase I study

Dr Reddy's Laboratories Ltd announced that its DRL_TC tocilizumab biosimilar candidate met primary and secondary endpoints in a Phase I study. This Phase I study compared the pharmacokinetic equivalence, safety, and immunogenicity of Dr. Reddy's ...

Coherus BioSciences to Release Humira biosimilar at $995 per carton

Coherus BioSciences Inc said last week it plans to launch a biosimilar of AbbVie Inc's Humira in July at a list price of $995 per carton, representing a discount of about 85 per cent from the bzlockbuster arthritis drug...

Pharma Sector To Surpass $130 bn mark by 2030

Hyderabad, known as India's pharma hub, is home to 214 USFDA-approved facilities, and as the pharma market grows due to complex molecules, companies will be forced to invest in and build future state-of-the-art labs, according to a Dr Reddy's...

PAG-led Sekhmet Pharmaventures Assigns Anil Khubchandani as MD & CEO

Anil Khubchandani has been appointed as managing director and CEO of Sekhmet Pharmaventures Pvt Ltd, an investment platform established to nurture and grow India's next generation of active pharmaceutical ingredient (API) companies, by a private...

CDSCO Authorises AstraZeneca's Anti-Liver Cancer Drug Combination

AstraZeneca, a British-Swedish pharmaceutical company, announced this week that its anti-liver cancer drug tremelimumab combination has been approved by India's drug regulator...

mRNA a promising technology for Asia-Pacific (APAC) vaccine manufacturers, says Merck Study

A new study has termed mRNA technology a ‘game-changer’ for Asia-Pacific (APAC) vaccine manufacturers. The study, sponsored by science and technology company Merck, surveyed nearly 40 manufacturers. Out of which, eighty-seven per cent of those...

Venus Remedies Gets Marketing Approval From Saudi Arabia For Chemotherapy Drug Docetaxel

Venus Remedies Ltd announced this week that it has received marketing authorization from Saudi Arabia for Docetaxel, a commonly used chemotherapy drug. The announcement comes three months after the company received Saudi Food and Drug Authority...

US FDA Granted Approval to Pfizer's RSV vaccine

Pfizer Inc's respiratory syncytial virus (RSV) vaccine for older adults was approved by the US Food and Drug Administration on Wednesday, making it the second shot against the common respiratory disease that can be fatal for seniors...

DKMS Assists Four Young Scientists In Advancing Blood Cancer Therapy

DKMS Stiftung Leben Spenden awards four outstanding young scientists with the highly endowed DKMS John Hansen Research Grant: Ivan Cohen, PhD, from the University of Pennsylvania, Eiko Hayase, MD, PhD, from the University of Texas MD...

Lupin, Enzene Biosciences Announce Strategic Partnership to launch Cetuximab in India

Lupin, Enzene Biosciences Announce Strategic Partnership to launch Cetuximab in India

© 2024 India Pharma Outlook. All Rights Reserved.